Representative Transactions

Area of Expertise: Targeted Indications

BJC Capital Advisors has been involved in transactions across a broad array of disease indications including:

• ​allergy and autoimmune disorders
• cardio-renal
• endocrine/metabolic
• immunological disorders
• infectious diseases
• gastrointestinal
• neurodegenerative disorders
• neurological - pain management
• neurological - addiction disorders
• oncology
• ophthalmology
• orthopedic
• precision medicine
• rare disease
• specialty pharmaceuticals

Our engagements have spanned drugs and drug candidates utilizing a breadth of treatment modalities.  Transaction experience has involved numerous therapeutic technologies including:  

Area of Expertise: Therapeutic Treatment Modalities

• autologous/allogeneic cell therapy
• antibody drug conjugates (ADCs)
• compounded pharmaceuticals
• gene editing technologies
• gene therapy
• monoclonal antibody technology
• novel delivery technologies
• small molecule
• vaccine technologies